Harriet V Mears - Francis Crick Inst

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 23 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

ER-export and ARFRP1/AP-1-dependent Delivery of SARS-CoV-2 Envelope to Lysosomes Controls Late Stages of Viral Replication

Guy J. Pearson,Harriet V. Mears,Malgorzata Broncel,Ambrosius P. Snijders,David L. V. Bauer,Jeremy G. Carlton

SCIENCE ADVANCESno. 14 (2024)

Cited5Views0WOSSCIENCEBibtex

33 Fourth Dose Bivalent Mrna Vaccines Containing BA.1 Significantly Augment Neutralising Antibody Titres Against SARS-COV-2 Omicron Sub-Lineages XBB and BQ.1.1 in Healthy Adults

Mary Wu,Edward Carr,Ruth Harvey,Joshua Gahir,Hermaleigh Townsley, Guilia Dowgier, Agnieska Hobbs,Lou Herman,Martina Ragno,Murad Miah,Philip Bawumia,Callie Smith,Mauro Miranda,Harriet Mears,Lorin Adams, Emine Haptioglu,Nicola O'Reilly,Scott Warchal,Chelsea Sawyer,Karen Ambrose

Clinical Infection in Practice (2023): 100260

Cited0Views0Bibtex

Neutralising Immunity to Omicron Sublineages BQ.1.1, XBB, and XBB.1.5 in Healthy Adults is Boosted by Bivalent BA.1-containing Mrna Vaccination and Previous Omicron Infection

Edward J Carr,Mary Y Wu,Joshua Gahir,Ruth Harvey,Hermaleigh Townsley,Chris Bailey,Ashley S Fowler,Giulia Dowgier,Agnieszka Hobbs,Lou Herman,Martina Ragno,Murad Miah, Phillip Bawumia,Callie Smith,Mauro Miranda,Harriet V Mears,Lorin Adams,Emine Haptipoglu,Nicola O’Reilly,Scott Warchal

The Lancet Infectious Diseasesno. 7 (2023): 781-784

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn